机器人辅助体内尿流改道的技术现状和预后分析（附光盘）  

A review of current techniques and outcomes of robot-assisted intracorporeal urinary diversion

作　　者：张古田[1] 云天纬 郭宏骞[1] ZHANG Gu-tian;YUN Tian-wei;GUO Hong-qian(Department of Urology Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School of Nanjing University,Nanjing 210008;Medical School of Southeast University,Nanjing 210009,China)

机构地区：[1]南京大学医学院附属鼓楼医院泌尿外科,江苏南京210008 [2]东南大学医学院,江苏南京210009

出　　处：《现代泌尿外科杂志》2019年第10期781-785,共5页Journal of Modern Urology

摘　　要：通过复习文献和总结作者施行体内尿流改道(ICUD)手术的实践经验,介绍国内外机器人辅助ICUD手术(包括回肠原位新膀胱、回肠输出道和经皮可控回结肠膀胱)的技术现状,并对手术及术后近远期预后进行分析。机器人辅助体内尿流改道保持甚至改善了手术过程、术后并发症和功能结果,但仍需更多的随访时长、样本量大的随机临床对照试验数据来确定体内、体外尿流改道的优缺点。Robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is being progressively performed worldwide.A brief summary of recent technical developments and outcome data of RARC with ICUD is offered in this review,including intracorporeal ileal neobladder,ileal outlet and percutaneous controllable ileocolic neobladder.RARC with intracorporeal urinary diversion is a feasible option for patients with bladder cancer as it can improve the surgical procedures,reduce postoperative complications and enhance the surgical outcomes.However,more prospective and randomized controlled trials are needed to verify the benefits of intracorporeal and extracorporeal urinary diversion.

关 键 词：机器人辅助腹腔镜膀胱癌根治术 体内尿流改道 体内回肠原位新膀胱 体内回肠输出道 体内可控回结肠膀胱 并发症 

分 类 号：R737.14[医药卫生—肿瘤]